Clinical trial NCT01545297 - References

Brain Tumor — Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery

Citation(s)

•   Bamgbade OA, Alfa JA
  Dexmedetomidine anaesthesia for patients with obstructive sleep apnoea undergoing bariatric surgery. Eur J Anaesthesiol. 2009 Feb;26(2):176-7. doi: 10.1097/EJA.0b013e32831a47cb.
•   Bekker AY, Kaufman B, Samir H, Doyle W
  The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg. 2001 May;92(5):1251-3.
•   Berkenstadt H, Perel A, Hadani M, Unofrievich I, Ram Z
  Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol. 2001 Jul;13(3):246-9.
•   Bhana N, Goa KL, McClellan KJ
  Dexmedetomidine. Drugs. 2000 Feb;59(2):263-8; discussion 269-70.
•   Blanshard HJ, Chung F, Manninen PH, Taylor MD, Bernstein M
  Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg. 2001 Jan;92(1):89-94.
•   Chawla S, Robinson S, Norton A, Esterman A, Taneerananon T
  Peri-operative use of dexmedetomidine in airway reconstruction surgery for obstructive sleep apnoea. J Laryngol Otol. 2010 Jan;124(1):67-72. doi: 10.1017/S002221510999123X. Epub 2009 Oct 26.
•   Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL
  Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990 Aug;10(4):244-51.
•   Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG
  A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia. 2007 Nov;62(11):1132-8.
•   Coles JP, Leary TS, Monteiro JN, Brazier P, Summors A, Doyle P, Matta BF, Gupta AK
  Propofol anesthesia for craniotomy: a double-blind comparison of remifentanil, alfentanil, and fentanyl. J Neurosurg Anesthesiol. 2000 Jan;12(1):15-20.
•   Conte V, Magni L, Songa V, Tomaselli P, Ghisoni L, Magnoni S, Bello L, Stocchetti N
  Analysis of propofol/remifentanil infusion protocol for tumor surgery with intraoperative brain mapping. J Neurosurg Anesthesiol. 2010 Apr;22(2):119-27. doi: 10.1097/ANA.0b013e3181c959f4.
•   Coursin DB, Coursin DB, Maccioli GA
  Dexmedetomidine. Curr Opin Crit Care. 2001 Aug;7(4):221-6. Review.
•   From RP, Warner DS, Todd MM, Sokoll MD
  Anesthesia for craniotomy: a double-blind comparison of alfentanil, fentanyl, and sufentanil. Anesthesiology. 1990 Nov;73(5):896-904.
•   Johnson KB, Egan TD
  Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations. J Neurosurg Anesthesiol. 1998 Jan;10(1):25-9. Erratum in: J Neurosurg Anesthesiol 1998 Apr;10(2):69.
•   Kamibayashi T, Maze M
  Clinical uses of alpha2 -adrenergic agonists. Anesthesiology. 2000 Nov;93(5):1345-9. Review.
•   Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA
  Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol. 2004 Jan;16(1):20-5.
•   Manninen PH, Balki M, Lukitto K, Bernstein M
  Patient satisfaction with awake craniotomy for tumor surgery: a comparison of remifentanil and fentanyl in conjunction with propofol. Anesth Analg. 2006 Jan;102(1):237-42.
•   Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M
  The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003 Feb;98(2):428-36.
•   Oda Y, Toriyama S, Tanaka K, Matsuura T, Hamaoka N, Morino M, Asada A
  The effect of dexmedetomidine on electrocorticography in patients with temporal lobe epilepsy under sevoflurane anesthesia. Anesth Analg. 2007 Nov;105(5):1272-7, table of contents.
•   Ramsay MA, Saha D, Hebeler RF
  Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth. 2006 Sep;18(6):452-4.
•   Sarang A, Dinsmore J
  Anaesthesia for awake craniotomy--evolution of a technique that facilitates awake neurological testing. Br J Anaesth. 2003 Feb;90(2):161-5.
•   Serletis D, Bernstein M
  Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg. 2007 Jul;107(1):1-6.
•   Silbergeld DL, Mueller WM, Colley PS, Ojemann GA, Lettich E
  Use of propofol (Diprivan) for awake craniotomies: technical note. Surg Neurol. 1992 Oct;38(4):271-2.
•   Souter MJ, Rozet I, Ojemann JG, Souter KJ, Holmes MD, Lee L, Lam AM
  Dexmedetomidine sedation during awake craniotomy for seizure resection: effects on electrocorticography. J Neurosurg Anesthesiol. 2007 Jan;19(1):38-44.
•   Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM
  Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999 Dec;54(12):1136-42.

Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery: a Randomized Controlled Trial

Details for clinical trial NCT01545297